Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

ClinicalTrials.gov ID: NCT05660382

Public ClinicalTrials.gov record NCT05660382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 12:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Phase III Study of the Efficacy and Safety of Miconazole Oil, Active Versus Placebo in the Treatment of Otomycosis

Study identification

NCT ID
NCT05660382
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hill Dermaceuticals, Inc.
Industry
Enrollment
112 participants

Conditions and interventions

Conditions

Interventions

  • Miconazole (2%) oil and mineral oil Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2023
Primary completion
Dec 26, 2024
Completion
Dec 26, 2024
Last update posted
May 11, 2026

2023 – 2024

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Head and Neck Surgery Specialist Chula Vista California 91910
Advanced ENT & Allergy Louisville Kentucky 40220
Charleston ENT Associates, LLC North Charleston South Carolina 29406
Carolina ENT Orangeburg South Carolina 29118
Spartanburg / Greer ENT & Allergy Spartanburg South Carolina 29303
Alamo ENT Associates San Antonio Texas 78258
ENT Center Of Utah Salt Lake City Utah 84102

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05660382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05660382 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →